Analysis of Risk Factors of Diabetic Retinopathy
Analysis of Risk Factors in the Development of Diabetic Retinopathy in Assuit University Hospital
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The aim of the study is to analyse the risk factors involved in the development of diabetic retinopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2023
CompletedFirst Posted
Study publicly available on registry
December 4, 2023
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedDecember 4, 2023
November 1, 2023
4 months
November 24, 2023
December 1, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
aeffect of risk factors in progression of diabetic retinopathy.
analysis of risk factors affecting progression of diabetic retinopathy and test if they can be modified or not.
baseline
Interventions
1. The Slit lamb is a biomicroscope. It emits a beam of light that can be varied in height and width. It allows visualization of the anterior segment of the eye. With auxiliary lenses, the examiner can also view the posterior segment. These lenses are simple, affordable, and portable. Although high-end devices like fundus cameras and optical coherence tomography have revolutionized how practitioners detect eye diseases, they can never replace these handheld lenses. 2. OCT is a noninvasive method that yields a cross-section image of the retina by exposing the eye to near-infrared light. Specifically, an emitted light beam is scattered and reflected back by the retinal surface as well as its different layers.
Eligibility Criteria
Population-based, cross-sectional survey using the standardised Rapid Assessment of Avoidable Blindness with the addition of the Diabetic Retinopathy module methodology.
You may qualify if:
- All patients with confirmed DR , best-corrected visual acuity BCVA (using a Snellen chart) in each eye to allow the performance of the protocol, and intraocular pressure less than 21 mmHg.
- . proliferative diabetic retinopathy with or without high-risk characteristics (HRCs) (any three of the following):
- presence of neovessels
- location of the neovessels (at the optic nerve)
- size of the neovessels: if at the optic nerve \[neovascularisation of the disc (NVD)\] ≥ ¼-⅓ disc area if elsewhere in the retina \[neovascularisation of the retina elsewhere (outside the disc) (NVE) ≥ ½ of the disc area (if both NVD and NVE present, classified based on neovessels at the disc)
- presence of pre-retinal haemorrhage or vitreous haemorrhage. About half of patients with severe or very severe NPDR will progress to PDR within a year.
- Symptoms include sudden de crease of V/A , appearance of flashes and floaters, visual field defects.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
November 24, 2023
First Posted
December 4, 2023
Study Start
June 1, 2024
Primary Completion
October 1, 2024
Study Completion
June 1, 2025
Last Updated
December 4, 2023
Record last verified: 2023-11